Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: vincristine sulfate

« Back to Dashboard
Vincristine sulfate is the generic ingredient in six branded drugs marketed by Talon Therap, Lilly, Teva Parenteral, Bristol Myers Squibb, Abic, Abraxis Pharm, Fresenius Kabi Usa, Hospira, and Teva Pharms Usa, and is included in thirteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has forty-seven patent family members in fifteen countries.

There are thirteen drug master file entries for vincristine sulfate. One supplier is listed for this compound.

Summary for Generic Name: vincristine sulfate

Tradenames:6
Patents:3
Applicants:9
NDAs:13
Drug Master File Entries: see list13
Suppliers: see list1
Formulation / Manufacturing:see details

Clinical Trials for: vincristine sulfate

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
ONCOVIN
vincristine sulfate
INJECTABLE;INJECTION014103-003Mar 7, 1984DISCNNo<disabled><disabled>
Abic
VINCRISTINE SULFATE
vincristine sulfate
INJECTABLE;INJECTION070873-001Feb 19, 1987DISCNNo<disabled><disabled>
Hospira
VINCRISTINE SULFATE
vincristine sulfate
INJECTABLE;INJECTION071561-001Apr 11, 1988DISCNNo<disabled><disabled>
Talon Therap
MARQIBO KIT
vincristine sulfate
INJECTABLE, LIPOSOMAL;INTRAVENOUS202497-001Aug 9, 2012RXYes<disabled><disabled>
Teva Parenteral
VINCASAR PFS
vincristine sulfate
INJECTABLE;INJECTION071426-001Jul 17, 1987DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: vincristine sulfate

Country Document Number Publication Date
Australia7164601Jan 14, 2002
Canada2412790Jan 10, 2002
Japan2012092148May 17, 2012
Japan2012158602Aug 23, 2012
World Intellectual Property Organization (WIPO)0202077Jan 10, 2002
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc